People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Solarea Bio, Inc. | — | Biotechnology | Series A | $37.2M | $27.2M | 2025 |
| Kindra Corp | — | Other | Pre-Seed | $1.0M | $4.6M | 2024 |
CATHERINE BALSAM-SCHWABER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside CATHERINE BALSAM-SCHWABER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Walker | 1 | 11 |
| Anula Jayasuriya | 1 | 5 |
| NEAL BHADKAMKAR | 1 | 4 |
| Anna Barber | 1 | 3 |
| GREGORY SIECZKIEWICZ | 1 | 2 |
| Maxim Rubin | 1 | 1 |
| ERIC SCHOTT | 1 | 1 |
| ILISSA LARIMORE | 1 | 1 |
| GERARDO TOLEDO | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.